Moxetumomab pasudotox-tdfk Intravenous and Revonto Injection
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Revonto Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: dantrolene
Brand name: Dantrium, Revonto, Dantrium Intravenous, Ryanodex
Synonyms: Revonto
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Rexaphenac
- Moxetumomab pasudotox-tdfk Intravenous-Rexulti
- Moxetumomab pasudotox-tdfk Intravenous-Reyataz
- Moxetumomab pasudotox-tdfk Intravenous-Reyataz (Atazanavir Capsules)
- Moxetumomab pasudotox-tdfk Intravenous-Reyataz (Atazanavir Powder for Oral Suspension)
- Moxetumomab pasudotox-tdfk Intravenous-Reyvow
- Revonto Injection-Moxifloxacin
- Revonto Injection-Moxifloxacin (Systemic)
- Revonto Injection-Moxifloxacin Hydrochloride
- Revonto Injection-Moxifloxacin Injection
- Revonto Injection-Moxifloxacin Intravenous
- Revonto Injection-Moxifloxacin Tablets